Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/JU.0000000000001677 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Urological Outcomes and Adverse Events Following Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: A Single-center Retrospective Study.
Urology
December 2024
King's College London, London, United Kingdom; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. Electronic address:
Article Synopsis
- The study examines urological complications in patients who underwent total pelvic exenteration (TPE) for locally advanced and recurrent rectal cancer, highlighting a significant occurrence of issues post-surgery.
- A total of 128 patients were assessed, with common complications being transient acute kidney injury and urinary tract infections, resulting in an overall complication rate of 51.6%.
- The findings indicate that the type of cancer (LARC vs RRC) and prior radiation treatment did not significantly influence the rates of urological complications.
Risk factors for benign uretero-enteric anastomotic strictures after open radical cystectomy and ileal conduit.
Urologia
December 2024
Department of Urology, Gemelli isola Tiberina Hospital, Rome, Università Cattolica del Sacro Cuore, Rome, Italy.
Introduction And Objective: Radical Cystectomy (RC) is one of the most common and complex surgical procedures in urologic surgery, and benign ureteroenteric anastomosis strictures (UAS) are complications described in about 15% of patients undergoing RC with different urinary diversion (UD). The aim of this study is to evaluate and analyze risk factors related to the development of ureteral stenosis after RC.
Materials And Methods: All consecutive patients who underwent RC with ileal conduit from December 2019 to December 2022 were included.
Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit.
J Urol
December 2024
Division of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Purpose: Ureteral stents are commonly placed intraoperatively during radical cystectomy, although their efficacy in reducing complications is unproven. We compared clinical outcomes among patients undergoing robot-assisted radical cystectomy with intracorporeal ileal conduit (RARC-IC) with or without ureteral stents to determine if omission of ureteral stents affects postoperative complications.
Materials And Methods: All RARC-IC surgeries performed at our institution between November 2017 and June 2023 were reviewed.
Comparative perioperative outcomes of intravenous indocyanine green during robot-assisted cystectomy: a meta-analysis and systematic review.
J Robot Surg
November 2024
Department of Urology/School of Clinical Medicine, North Sichuan Medical College/Affiliated Hospital of North Sichuan Medical College, No. 1, South Maoyuan Road, Shunqing District, Nanchong, 63700, Sichuan, China.
This study aimed to evaluate the clinical utility of intravenous indocyanine green (ICG) in the context of robot-assisted cystectomy (RAC) through a systematic review and meta-analysis. The primary focus was to compare postoperative complications and perioperative outcomes between the ICG cohort and the non-ICG cohort. The primary outcome indicators were the incidence of ureteroenteric strictures and the number of strictures anastomoses.
View Article and Find Full Text PDFIntravenous indocyanine green to evaluate distal ureteral vascularity during robot-assisted radical cystectomy with intracorporeal urinary diversion.
World J Urol
October 2024
Department of Urology, Hospital Clínic de Barcelona, Villarroel 170, Barcelona, 08036, Spain.
Purpose: The aim of the present study is to assess the role of indocyanine green (ICG) to evaluate distal ureteral vascularity during robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion and its impact on the incidence of benign ureteroenteric strictures (UES).
Methods: The study included patients who underwent RARC for bladder cancer between 2018 and 2023. All patients included underwent intracorporeal urinary diversion with ileal conduit or neobladder.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!